Hypothermic oxygenated perfusion in extended criteria donor liver transplantation—A randomized clinical trial

Hypothermic Oxygenated Perfusion (HOPE) of the liver can reduce the incidence of early allograft dysfunction (EAD) and failure in extended criteria donors (ECD) grafts, although data from prospective studies are very limited. In this monocentric, open‐label study, from December 2018 to January 2021, 110 patients undergoing transplantation of an ECD liver graft were randomized to receive a liver after HOPE or after static cold storage (SCS) alone. The primary endpoint was the incidence of EAD. The secondary endpoints included graft and patient survival, the EASE risk score, and the rate of graft or other graft‐related complications. Patients in the HOPE group had a significantly lower rate of EAD (13% vs. 35%, p = .007) and were more frequently allocated to the intermediate or higher risk group according to the EASE score (2% vs. 11%, p = .05). The survival analysis confirmed that patients in the HOPE group were associated with higher graft survival one year after LT (p = .03, log‐rank test). In addition, patients in the SCS group had a higher re‐admission and overall complication rate at six months, in particular cardio‐vascular adverse events (p = .04 and p = .03, respectively). HOPE of ECD grafts compared to the traditional SCS preservation method is associated with lower dysfunction rates and better graft survival.

[1]  F. Tandoi,et al.  Outcome of liver transplantation with grafts from brain‐dead donors treated with dual hypothermic oxygenated machine perfusion, with particular reference to elderly donors , 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  F. Tacke,et al.  Hypothermic Oxygenated Machine Perfusion Reduces Early Allograft Injury and Improves Post-transplant Outcomes in Extended Criteria Donation Liver Transplantation From Donation After Brain Death , 2021, Annals of surgery.

[3]  T. Minor,et al.  Oxygenated End-Hypothermic Machine Perfusion in Expanded Criteria Donor Kidney Transplant: A Randomized Clinical Trial. , 2021, JAMA surgery.

[4]  A. Zanella,et al.  The Role of Ex Situ Hypothermic Oxygenated Machine Perfusion and Cold Preservation Time in Extended Criteria Donation After Circulatory Death and Donation After Brain Death , 2021, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  V. Sallinen,et al.  An unequivocal formula to calculate L-GrAFT-score is needed. , 2021, Journal of hepatology.

[6]  N. Heaton,et al.  Hypothermic Machine Perfusion in Liver Transplantation - A Randomized Trial. , 2021, The New England journal of medicine.

[7]  M. Cescon,et al.  How to Preserve Liver Grafts From Circulatory Death With Long Warm Ischemia? A Retrospective Italian Cohort Study With Normothermic Regional Perfusion and Hypothermic Oxygenated Perfusion , 2021, Transplantation.

[8]  A. M. Shapiro,et al.  The Actual Operative Costs of Liver Transplantation and Normothermic Machine Perfusion in a Canadian Setting , 2020, PharmacoEconomics - Open.

[9]  D. Abramowicz,et al.  Oxygenated versus standard cold perfusion preservation in kidney transplantation (COMPARE): a randomised, double-blind, paired, phase 3 trial , 2020, The Lancet.

[10]  V. Mazzaferro,et al.  Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant , 2020, JAMA surgery.

[11]  M. Clatworthy,et al.  Cytokine absorption during human kidney perfusion reduces delayed graft function–associated inflammatory gene signature , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  P. Clavien,et al.  Hypothermic Oxygenated Liver Perfusion (HOPE) Prevents Tumor Recurrence in Liver Transplantation From Donation After Circulatory Death. , 2020, Annals of surgery.

[13]  A. Mehrabi,et al.  The Differential Influence of Cold Ischemia Time on Outcome After Liver Transplantation for Different Indications—Who Is at Risk? A Collaborative Transplant Study Report , 2020, Frontiers in Immunology.

[14]  V. Ranieri,et al.  Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial , 2020, Scientific Reports.

[15]  V. Ranieri,et al.  Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Expanded Criteria Donors in Liver and Kidney Transplantation: Protocol for a Single-Center Randomized Controlled Trial , 2020, JMIR research protocols.

[16]  T. Frauenfelder,et al.  Perfusate adsorption during ex vivo lung perfusion improves early post-transplant lung function. , 2020, The Journal of thoracic and cardiovascular surgery.

[17]  D. Meierhofer,et al.  Novel Real-Time Prediction of Liver Graft Function During Hypothermic Oxygenated Machine Perfusion Before Liver Transplantation. , 2019, Annals of surgery.

[18]  Zhenhua Ma,et al.  Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation , 2019, Medicine.

[19]  P. Dutkowski,et al.  Machine perfusion strategies in liver transplantation. , 2019, Hepatobiliary surgery and nutrition.

[20]  M. Berenguer,et al.  Stretching the boundaries for liver transplant in the 21st century. , 2018, The lancet. Gastroenterology & hepatology.

[21]  N. Heaton,et al.  A randomized trial of normothermic preservation in liver transplantation , 2018, Nature.

[22]  P. Dutkowski,et al.  Hypothermic Machine Preservation of the Liver: State of the Art , 2018, Current Transplantation Reports.

[23]  J. Hiatt,et al.  Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model , 2017, JAMA surgery.

[24]  P. Friend,et al.  Preliminary Single‐Center Canadian Experience of Human Normothermic Ex Vivo Liver Perfusion: Results of a Clinical Trial , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  A. Cucchetti,et al.  Risk Avoidance and Liver Transplantation: A Single-center Experience in a National Network , 2016, Annals of surgery.

[26]  P. Clavien,et al.  First Comparison of Hypothermic Oxygenated PErfusion Versus Static Cold Storage of Human Donation After Cardiac Death Liver Transplants: An International-matched Case Analysis. , 2015, Annals of surgery.

[27]  D. Abbott,et al.  Hospital utilization and consequences of readmissions after liver transplantation. , 2014, Surgery.

[28]  P. Clavien,et al.  Protective mechanisms of end-ischemic cold machine perfusion in DCD liver grafts. , 2013, Journal of hepatology.

[29]  M. Abecassis,et al.  Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[30]  D. Mirza,et al.  The marginal liver donor – an update , 2008, Transplant international : official journal of the European Society for Organ Transplantation.

[31]  J. Bragg-Gresham,et al.  Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[32]  M. Morino,et al.  Effect of extended cold ischaemia with UW solution on graft function after liver transplantation , 1992, The Lancet.

[33]  J H Southard,et al.  Principles of solid-organ preservation by cold storage. , 1988, Transplantation.